Dimitrios Tsiantoulas

Dimitrios Tsiantoulas

Auto-generated profile, based on publicly available information

Dimitrios Tsiantoulas

Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2013 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
YZYasmine Zouggari
Yasmine Zouggari
HAHafid Ait-Oufella
Hafid Ait-Oufella
PBPhilippe Bonnin
Philippe Bonnin
TSTabassome Simon
Tabassome Simon
ASAndrew P Sage
Andrew P Sage
ZMZiad Mallat
Ziad Mallat

8 November 2018 in Nature Reviews Cardiology
Verified
Journal Article
Closed access
PDF file
ASAndrew P. Sage
Andrew P. Sage
DTDimitrios Tsiantoulas
Dimitrios Tsiantoulas
CBChristoph J. Binder
Christoph J. Binder
ZMZiad Mallat
Ziad Mallat

23 May 2014 in Circulation Research
Verified
Journal Article
Closed access
PDF file
DTDimitrios Tsiantoulas
Dimitrios Tsiantoulas
CDCody J. Diehl
Cody J. Diehl
JWJoseph L. Witztum
Joseph L. Witztum
CBChristoph J. Binder
Christoph J. Binder
Insights into the important contribution of inflammation and immune functions in the development and progression of atherosclerosis have greatly improved our understanding of this disease. Although the role of T cells has been extensively studied for decades, only recently has the role of B cells gained more attention. Recent studies have identified differential effects of different B-cell subsets and helped to clarify the still poorly understood mechanisms by which these act. B1 cells have been shown to prevent lesion formation, whereas B2 cells have been suggested to promote it. Natural IgM antibodies, mainly derived from B1 cells, have been shown to mediate atheroprotective effects, but the functional role of other immunoglobulin classes, particularly IgG, still remains elusive. In this review, we will focus on recent insights on the role of B cells and various immunoglobulin classes and how these may mediate their effects in atherosclerotic lesion formation. Moreover, we will highlight potential therapeutic approaches focusing on B-cell depletion that could be used to translate experimental evidence to human disease.

1 July 2012 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Closed access
ASAndrew P. Sage
Andrew P. Sage
DTDimitrios Tsiantoulas
Dimitrios Tsiantoulas
LBLauren Baker
Lauren Baker
JHJames Harrison
James Harrison
LMLeanne Masters
Leanne Masters
ZMZiad Mallat
Ziad Mallat
Objective—: The goal of this study was to assess the role of B-cell activating factor (BAFF) receptor in ­B-­cell regulation of atherosclerosis. Methods and Results—: Male LDL ­receptor-­deficient mice ( Ldlr −/− ) were lethally irradiated and reconstituted with either wild type or BAFF receptor (BAFF-R)–deficient bone marrow. After 4 weeks of recovery, mice were put on a ­high-­fat diet for 6 or 8 weeks. ­BAFF-­R deficiency in bone marrow cells led to a marked reduction of conventional mature B2 cells but did not affect the B1a cell subtype. This was associated with a significant reduction of dendritic cell activation and ­T-­cell proliferation along with a reduction of IgG antibodies against ­malondialdehyde-­modified low-density lipoprotein. In contrast, serum IgM type antibodies were preserved. Interestingly, ­BAFF-­R deficiency was associated with a significant reduction in atherosclerotic lesion development and reduced numbers of plaque T cells. Selective ­BAFF-­R deficiency on B cells led to a similar reduction in lesion size and ­T-­cell infiltration but in contrast did not affect dendritic cell activation. Conclusion—: BAFF-­R deficiency in mice selectively alters mature B2 ­cell-­dependent cellular and humoral immune responses and limits the development of atherosclerosis.

17 April 2017 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
MNMeritxell Nus
Meritxell Nus
ASAndrew P Sage
Andrew P Sage
YLYuning Lu
Yuning Lu
LMLeanne Masters
Leanne Masters
BLBrian Lam
Brian Lam
ZMZiad Mallat
Ziad Mallat

6 April 2015 in Nature Immunology
Verified
Journal Article
Closed access
RÜRudolf Übelhart
Rudolf Übelhart
EHEva Hug
Eva Hug
MBMartina P Bach
Martina P Bach
TWThomas Wossning
Thomas Wossning
MMMarcus Dühren-Von Minden
Marcus Dühren-Von Minden
HJHassan Jumaa
Hassan Jumaa